Skip to main content


Press Release
Stockholm, Sweden, July 21, 2009

Elekta and C-RAD have reached an agreement where the Sentinel™ laser scanner
system has been selected as the Elekta preferred solution for optical surface
tracking. Elekta's customers will be offered this superior technology for
patient positioning and intra fraction motion detection without the use of


In response to an increasing demand from customers for a ‘contactless' patient
positioning and monitoring solution, Elekta has chosen to partner with C-RAD
due to a close match in philosophies of personalized medicine, efficiency and
minimal invasiveness. 


The C-RAD Sentinel™ is an advanced laser-camera based system that can be used
for multiple applications within the field of radiation therapy. In contrast to
alternative approaches, by using advanced laser surface scanning technology the
need for implanted or even surface located reference markers is avoided. This
approach delivers workflow efficiencies for the clinic and greater comfort for
the patient. 


“This collaboration with C-RAD ensures that Elekta continues to provide the
most comprehensive Motion Management solutions to support our customer's
freedom to choose the best treatment approach for each individual patient. It
is therefore entirely complementary to our existing product portfolio and open
systems philosophy,” says Jill Stief, Elekta Director Product Management
Oncology Systems. 


“This collaboration with Elekta is of strategic importance and gives us a
tremendous leverage for reaching out to radiation therapy centers worldwide,”
says Erik Hedlund, CEO at C-RAD AB. 


"The Sentinel System is an ideal solution for intra fraction motion monitoring
especially in combination with the HexaPOD™ evo RT system. Identified patient
movements during the treatment can like this be repositioned very quickly. The
patient error correction values obtained by the Sentinel scan can then be
utilized by iGUIDE® to accurately reposition the patient ensuring continuity of
effective and efficient treatment," says A.B. Claudio Karpf, Elekta Product
Manager robotic systems / MMS. 


According to the agreement, the Sentinel™ system is now being made available
through the Elekta sales and distribution network to Elekta customers


For further information, please contact:


Stina Thorman, Investor Relations, Elekta AB, Phone +46 8 587 25 437



Michelle Lee, Director Marketing Services, Elekta AB, Phone +1-770-670-2447 


Erik Hedlund, CEO C-RAD AB, Phone +46-18-666931, E-mail






About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated state of the art tools and treatment planning systems for
radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care. 


Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives,
making the future possible today. 


Today, Elekta solutions in oncology and neurosurgery are used in over 5,000
hospitals globally, and every day more than 100,000 patients receive diagnosis,
treatment or follow-up with the help of a solution from the Elekta Group. 


Elekta employs around 2,500 employees globally. The corporate headquarter is
located in Stockholm, Sweden, and the company is listed on the Nordic Exchange
under the ticker EKTAb. For more information about Elekta, please visit 


About C-RAD

C-RAD develops new and innovative solutions for the use in advanced radiation
therapy. The company group of C-RAD offers products and solutions for patient
positioning, tumor localization and radiation treatment systems. End users are
radiation therapy clinics worldwide. 


All product development is conducted in three fully owned subsidiaries; C-RAD
Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is
located in Östersund while the other companies are located in Uppsala. 


The activities in C-RAD AB originate in research and development at the
Karolinska Institutet in Solna and the Royal Institute of Technology in
Stockholm. Sales of the company's first product, the C-RAD Sentinel™, started
during autumn 2006. C-RAD AB is a listed company on Aktietorget since 23 July
2007. For more information on C-RAD, please visit 
Close Menu